FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

40757911000001103: Tapimio 50mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Aug 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2315601000001116 Tapimio 50mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2315621000001111 Tapimio 50mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tapimio 50mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Tapimio 50mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Tapimio 50mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Has AMP Tapimio 50mg modified-release capsules (Neuraxpharm UK Ltd) true Inferred relationship Existential restriction modifier
Tapimio 50mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Is a Tapentadol 50mg modified-release capsules 56 capsule true Inferred relationship Existential restriction modifier
Tapimio 50mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Tapimio 50mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Has dispensed dose form Modified-release oral capsule true Inferred relationship Existential restriction modifier
Tapimio 50mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tapimio 50mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tapimio 50mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Has specific active ingredient Tapentadol phosphate true Inferred relationship Existential restriction modifier
Tapimio 50mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Tapimio 50mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tapentadol true Inferred relationship Existential restriction modifier
Tapimio 50mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tapimio 50mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start